Click here to read the articles and download the PDF

Pharmaceutical Commerce - December 2024

Because of the potential for product shortages at pharmacies, the FDA has not only given industry more time for compliance—but time to catch up on boosting the supply chain’s interoperable efforts.

Did Industry Fumble the DSCSA Deadline?

A crash course on the bubble itself, including therapeutic areas most affected.

Going Inside the Gross-to-Net Bubble and Its Nuances

Addressing the bottlenecks in cell and gene therapy manufacturing through a well-designed artificial intelligence approach is essential to avoiding data siloes.

Why AI Advances in CGT Require Getting Data Right

Videos

In the fifth part of this roundtable discussion, subject matter experts discuss the role that various GS1 initiatives have played, and provide a breakdown of stakeholders who have benefitted greatly from RFID.

Peer Exchange: The Impact of RAIN RFID (Episode 5)

Articles

As a result, the provider increases its involvement in the country’s pharma sector. 

LSPedia Opens New Office in Hyderabad, India

The latest news for pharma industry insiders.

Pharma Pulse 12/20/24: Leveraging Telehealth to Improve Access to Rare/Complex Disease Care, Transforming Pharmacy Professionals’ Mental Health & more

A cohort study explores the connection between the two, along with the impact of educational attainment on this relationship. 

The Potential Association Between Allostatic Load and Male Cancer Mortality

Pharma Pulse 12/19/24: The Lifespan of Mature Drugs in 2025, Women have a Greater Genetic Risk for PTSD & more

Bill Trombetta, PhD, professor, healthcare strategy, marketing, St. Joseph's University, discusses observations in enterprise value growth and enterprise value-to-sales ratios among top biopharmaceutical companies. 

Trade & Channel Strategies 2024: Trends in Enterprise Value Growth and Value-to-Sales Ratios

Podcasts

Vibhu Tewary offers insight on this market segment, including a behind-the-scenes of what goes into designing a report. 

The Path Forward for Infused Biosimilars in the US

Pharma Pulse 12/18/24: The Art of Cross-Cultural Communication in Pharma, The Role of a Digital Navigator in Mental Health & more

Cheryl Allen, BS Pharm, MBA, founding partner, Curatio Scientia Advisors, discusses "Enhancing Patient Access and Support Through Technology: A Comprehensive Assessment," and upcoming industry challenges.  

Trade & Channel Strategies 2024: Boosting Patient Support & Engagement Across Care Settings

The 430,000 square-foot finished production facility will house multiple product types within the rare disease sector, including hemophilia. 

Featured Content

Pharmaceutical Commerce - December 2024

Did Industry Fumble the DSCSA Deadline?

Going Inside the Gross-to-Net Bubble and Its Nuances

Why AI Advances in CGT Require Getting Data Right